Current state and novel outlook on prevention and treatment of rising antibiotic resistance in urinary tract infections
Open Access
- 6 July 2024
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 261, 108688
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Oral Faropenem Sodium — Implications for Antimicrobial Resistance and Treatment EffectivenessIndian Pediatrics, 2022
- Non-antibiotic Approaches to Preventing Pediatric UTIs: a Role for D-Mannose, Cranberry, and Probiotics?Current Urology Reports, 2022
- Efficacy of vaccination with StroVac for recurrent urinary tract infections in women: a comparative single-centre studyInternational Urology and Nephrology, 2021
- Oral Antibiotics in Clinical Development for Community-Acquired Urinary Tract InfectionsInfectious Diseases and Therapy, 2021
- Threats of antibiotic resistance: an obliged reappraisalInternational Microbiology, 2021
- Orally Administered Amoxicillin/Clavulanate: Current Role in Outpatient TherapyInfectious Diseases and Therapy, 2020
- Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year periodEuropean Journal of Clinical Microbiology & Infectious Diseases, 2019
- Prevention and treatment of uncomplicated lower urinary tract infections in the era of increasing antimicrobial resistance—non-antibiotic approaches: a systemic reviewArchives of Gynecology and Obstetrics, 2019
- Ceftibuten plus amoxicillin-clavulanic acid for oral treatment of urinary tract infections with ESBL producing E. coli and K. pneumoniae: a retrospective observational case-seriesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2018
- Viral lower urinary tract infectionsCurrent Urology Reports, 2007